$TCBP News
Last published 1y ago
- 1y agoTCBPTC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) PatientPR NewswireTC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company pioneering gamma delta T cell therapies for the treatment of...
- 1y agoTCBPTCBP Announces Transition from Nasdaq to OTC MarketsPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces Outsourcing Initiatives, Reducing Burn Rate and OverheadPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical CompanyPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO ForumPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) , a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical TrialPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical TrialPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP to Implement ADS Ratio ChangePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces H5N1 Proof of Concept Studies IntentionPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP to Present at Sequire Investor Summit 2025PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Issues 25% Stock DividendPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Trading Continues Unabated on Nasdaq Stock ExchangePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Provides Update on Acquisition Strategy and Current TargetsPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 PatientsPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder DividendPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPCDNATCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical TrialPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 1y agoTCBPTCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Responds to False Social Media ClaimPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Site Opening of Guys and St. Thomas HospitalPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP to Present at the 2024 ThinkEquity Conference in NYCPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces First Patient Completed the Full Dose Regimen in ACHIEVE Clinical TrialPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferencePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Dosing of 5 New Patients in ACHIEVEPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Closing of Upsized $6.0 Million Public OfferingPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral IndicationsPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Closing of $2.0 Million Public OfferingPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Pricing of $2.0 Registered Direct OfferingPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Plan to Implement ADS Ratio ChangePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Launch of Compassionate Use Program for TCB008PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsPR NewswireTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Adjourns General Meeting Until a Later DatePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Exercise of Series D Warrants For CashPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces Shareholder Update Call on March 5th 2024PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK TrialPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit EuropePR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBP Provides Shareholder Update and Highlights Upcoming MilestonesPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
- 2y agoTCBPTCBPWTC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'PR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...
- 2y agoTCBPTC BioPharm to Present at the Sequire Investor SummitPR NewswireTC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...